Formoterol Fumarate, Budesonide

5 trials

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

0 Recruiting

4 Completed trials

1 Sponsors

11 Countries

Phase III

Phase II

Phase III/IV

Phase III: 3 Phase II: 1 Phase III/IV: 1

Oversight events:

1 serious breach across 1 trial

View oversight register →

Indications tested

Asthma 4 Chronic obstructive pulmonary disease 1

Sponsors using this IMP

AstraZeneca AB 5

All trials

5 total

A Phase II study to investigate lung function with 2 different doses of inhaled glycopyrronium taken with BFF compared to BFF in participant… Pending

2025-524914-26-00 Phase II 3 countries AstraZeneca AB
A Study to Evaluate the Effect of BGF MDI, BFF MDI and Placebo MDI on Exercise Parameters in Participants with COPD Ended

2022-502274-16-00 Phase III/IV 2 countries AstraZeneca AB
Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler in Patients with Inadequately Controlled Asthma Ended

2024-513568-24-00 Phase III 3 countries AstraZeneca AB
"A Variable Length Study to Evaluate the Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol inhaler in Adults and Adolescents with … Ended

2023-505787-11-00 Phase III 6 countries AstraZeneca AB
A Variable Length Study to Evaluate the Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol inhaler in Adults and Adolescents with S… Ended

2023-505786-88-00 Phase III 5 countries Astrazeneca AB

Showing 1–5 of 5 trials

← All drugs A–Z